Brian Mueller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Mueller
Brian Mueller is recorded as CEO at Grand Canyon Education, Inc. (LOPE) and CFO at Biomarin Pharmaceutical Inc (BMRN). The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $6,831,812 for Brian Mueller in fiscal 2025, including a base salary of $721,154. Disclosed compensation is on record for 9 fiscal years. Brian Mueller has spoken on 52 earnings calls and 1 other investor event across 2 companies, most recently for Biomarin Pharmaceutical Inc on August 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara Bodem Board Member
- Barbara W. Bodem Board Member
Leadership on record at Grand Canyon Education, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel J. Briggs CEO
- Daniel Bachus CFO
- Lori Browning CFO
- Dr. W. Stan Meyer COO
- Dilek Marsh CTO, CIO
- Joseph N. Mildenhall CIO
- Chevy Humphrey Board Member
- Kevin F. Warren Board Member
- Lisa Graham Keegan Board Member
- Sara R. Dial Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, CFO | $721,154 | $6,831,812 |
| 2024 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, CFO | $699,231 | $5,498,568 |
| 2023 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, CFO | $666,346 | $4,854,192 |
| 2022 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, CFO | $624,231 | $5,107,284 |
| 2021 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Finance and CFO | $600,000 | $4,699,165 |
| 2020 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Finance and CFO | $600,923 | $5,840,531 |
| 2019 | Grand Canyon Education, Inc. (LOPE) | Chief Executive Officer and Chairman (Principal Executive Officer) | $321,000 | $1,929,086 |
| 2019 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Finance and CFO | $417,235 | $1,676,536 |
| 2018 | Grand Canyon Education, Inc. (LOPE) | Chief Executive Officer and Chairman (Principal Executive Officer) | $487,673 | $2,361,195 |
| 2018 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President and Chief Financial Officer Daniel Spiegelman Former Executive Vice President, Chief Financial Officer | $402,712 | $1,524,685 |
| 2017 | Grand Canyon Education, Inc. (LOPE) | Chief Executive Officer and Chairman (Principal Executive Officer) | $642,000 | $2,799,914 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.